Your browser doesn't support javascript.
loading
Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability.
Holen, Børge; Kutrolli, Gleda; Shadrin, Alexey A; Icick, Romain; Hindley, Guy; Rødevand, Linn; O'Connell, Kevin S; Frei, Oleksandr; Parker, Nadine; Tesfaye, Markos; Deak, Joseph D; Jaholkowski, Piotr; Dale, Anders M; Djurovic, Srdjan; Andreassen, Ole A; Smeland, Olav B.
Affiliation
  • Holen B; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway. Electronic address: borge.holen@medisin.uio.no.
  • Kutrolli G; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Shadrin AA; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Icick R; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway; INSERM UMR-S1144, Université Paris Cité, F-75006, France.
  • Hindley G; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Rødevand L; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • O'Connell KS; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Frei O; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Parker N; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Tesfaye M; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Deak JD; Yale School of Medicine, New Haven, CT, USA; VA Connecticut Healthcare Center, West Haven, CT, USA.
  • Jaholkowski P; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Dale AM; Department of Radiology, University of California San Diego, La Jolla, CA 92093, USA; Multimodal Imaging Laboratory, University of California San Diego, La Jolla, CA 92093, USA; Department of Cognitive Science, University of California San Diego, La Jolla, CA, USA; Department of Psychiatry, Universi
  • Djurovic S; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Andreassen OA; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway.
  • Smeland OB; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo 0407, Norway. Electronic address: o.b.smeland@medisin.uio.no.
Drug Alcohol Depend ; 256: 111058, 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-38244365
ABSTRACT

BACKGROUND:

Opioid use disorder (OUD), a serious health burden worldwide, is associated with lower cognitive function. Recent studies have demonstrated a negative genetic correlation between OUD and general cognitive ability (COG), indicating a shared genetic basis. However, the specific genetic variants involved, and the underlying molecular mechanisms remain poorly understood. Here, we aimed to quantify and identify the genetic basis underlying OUD and COG.

METHODS:

We quantified the extent of genetic overlap between OUD and COG using a bivariate causal mixture model (MiXeR) and identified specific genetic loci applying conditional/conjunctional FDR. Finally, we investigated biological function and expression of implicated genes using available resources.

RESULTS:

We estimated that ~94% of OUD variants (4.8k out of 5.1k variants) also influence COG. We identified three novel OUD risk loci and one locus shared between OUD and COG. Loci identified implicated biological substrates in the basal ganglia.

CONCLUSION:

We provide new insights into the complex genetic risk architecture of OUD and its genetic relationship with COG.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Genome-Wide Association Study / Opioid-Related Disorders Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2024 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Genome-Wide Association Study / Opioid-Related Disorders Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2024 Type: Article